PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: Development, physicochemical and biological characterization

Volume: 627, Pages: 127144 - 127144
Published: Oct 1, 2021
Abstract
Prostate cancer is the second most common type of cancer in men, remaining the second leading cause of cancer-related deaths in this gender. In order to improve the security and efficacy of its treatment, nanostructured delivery systems have been widely studied. The present work aimed to develop and characterize polymeric nanoparticles based on a copolymer of polycaprolactone-DL-α-tocopherol-polyethylene glycol-1000 (PCL-block-TPGS) containing...
Paper Details
Title
PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: Development, physicochemical and biological characterization
Published Date
Oct 1, 2021
Volume
627
Pages
127144 - 127144
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.